|
WIPI2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28019994605211E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05839999945346E-07 |
| Normal-vs-Stage2 |
1.101350E-01 |
| Normal-vs-Stage3 |
8.76965167151411E-13 |
| Normal-vs-Stage4 |
1.798210E-03 |
| Stage1-vs-Stage2 |
7.922800E-01 |
| Stage1-vs-Stage3 |
4.296100E-03 |
| Stage1-vs-Stage4 |
9.314600E-01 |
| Stage2-vs-Stage3 |
1.701200E-01 |
| Stage2-vs-Stage4 |
7.782400E-01 |
| Stage3-vs-Stage4 |
8.053500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44799727763711E-11 |
| Normal-vs-AfricanAmerican |
6.921600E-01 |
| Normal-vs-Asian |
6.590000E-01 |
| Caucasian-vs-AfricanAmerican |
2.598400E-02 |
| Caucasian-vs-Asian |
1.848450E-01 |
| AfricanAmerican-vs-Asian |
5.560600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.3085003060005E-10 |
| Normal-vs-Female |
1.020500E-04 |
| Male-vs-Female |
2.733000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.861800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.38599999999867E-05 |
| Normal-vs-Age(61-80Yrs) |
2.65000021926198E-10 |
| Normal-vs-Age(81-100Yrs) |
5.126199464911E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.328000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.031600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.655800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.800180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.005500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.221540E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.962400E-03 |
| Normal-vs-Grade 2 |
4.17680001696397E-09 |
| Normal-vs-Grade 3 |
3.46179999999308E-07 |
| Normal-vs-Grade 4 |
4.24150000011281E-07 |
| Grade 1-vs-Grade 2 |
7.225800E-01 |
| Grade 1-vs-Grade 3 |
6.557400E-01 |
| Grade 1-vs-Grade 4 |
5.271200E-01 |
| Grade 2-vs-Grade 3 |
9.715200E-01 |
| Grade 2-vs-Grade 4 |
6.172600E-01 |
| Grade 3-vs-Grade 4 |
6.153400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62470037423645E-12 |
| Normal-vs-ccB subtype |
6.543600E-03 |
| ccA subtype-vs-ccB subtype |
1.456180E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42689999999657E-05 |
| Normal-vs-N1 |
9.422100E-02 |
| N0-vs-N1 |
8.695400E-01 |
|
|
